tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market
SGMT
Sagimet Biosciences, Inc. Class A
RESEARCH TOOLSreports

Sagimet Biosciences, Inc. Class A (SGMT) Stock News & Sentiment

Compare
1,677 Followers
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
11h ago
SGMT
Sagimet Biosciences: Advancing FASN Inhibitor Pipeline and Multi-Indication Opportunities Support Buy Rating and $26 Target
Premium
Ratings
Sagimet Biosciences: Advancing FASN Inhibitor Pipeline and Multi-Indication Opportunities Support Buy Rating and $26 Target
24d ago
SGMT
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
1M ago
PYXS
RGNX
Sagimet Highlights Positive MASH Combo Data and Pipeline Progress
Premium
Company Announcements
Sagimet Highlights Positive MASH Combo Data and Pipeline Progress
2M ago
8K
SGMT
Strategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
Premium
Ratings
Strategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
2M ago
SGMT
Sagimet Biosciences enters global license agreement with TAPI
Premium
Company Announcements
Sagimet Biosciences enters global license agreement with TAPI
2M ago
8K
SGMT
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
Premium
Ratings
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
2M ago
SGMT
More SGMT News >

SGMT News on the Web

Sagimet Biosciences initiated with an Equal Weight at Barclays
TipRanks News
Neutral
Sagimet Biosciences: Advancing FASN Inhibitor Pipeline and Multi-Indication Opportunities Support Buy Rating and $26 Target
TipRanks News
Bullish
Sagimet Biosciences Highlights Breakthrough Anti-Fibrotic Data Ahead of MASH-TAG 2026 Conference
Market Chameleon
Neutral
After-Hours Biotech Gainers: RVMD Soars On Merck Deal Talks Reports, SXTC, KALV, SGMT Rally
rttnews
Bullish
Why Sagimet Biosciences Inc.’s (SGMT) Stock Is Up 14.36%
AAII
Neutral
Why Sagimet Biosciences Inc.’s (SGMT) Stock Is Down 6.74%
AAII
Neutral
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
TipRanks News
Neutral
SGMT's Exclusive Resmetirom License Signals Bold Step Toward MASH Cirrhosis Therapy
Market Chameleon
Neutral

News Score - Last 7 Days

Neutral
SGMT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SGMT’s Media Buzz Sentiment?
1 articles about SGMT were published this week. In an average week, 1.25 articles are published.
    What is SGMT’s weekly average amount of articles?
    In an average week, 1.25 articles about SGMT are published.
      What is SGMT’s News Sentiment?
      50% of articles about SGMT were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        HVOOpen Orphan Plc
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week